Northern Trust’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-642,176
| Closed | -$7.93M | – | 4539 |
|
|
2024
Q4 | $7.93M | Sell |
642,176
-4,532
| -0.7% | -$51.9K | ﹤0.01% | 2257 |
|
|
2024
Q3 | $7.36M | Sell |
646,708
-19,736
| -3% | -$198K | ﹤0.01% | 2246 |
|
|
2024
Q2 | $4.76M | Sell |
666,444
-20,739
| -3% | -$159K | ﹤0.01% | 2432 |
|
|
2024
Q1 | $4.6M | Sell |
687,183
-3,493
| -0.5% | -$24K | ﹤0.01% | 2516 |
|
|
2023
Q4 | $4.49M | Sell |
690,676
-1,825
| -0.3% | -$11.8K | ﹤0.01% | 2569 |
|
|
2023
Q3 | $6.54M | Buy |
692,501
+1,761
| +0.3% | +$21.2K | ﹤0.01% | 2276 |
|
|
2023
Q2 | $9.65M | Buy |
690,740
+23,363
| +4% | +$398K | ﹤0.01% | 2096 |
|
|
2023
Q1 | $12.5M | Sell |
667,377
-4,486
| -0.7% | -$73.7K | ﹤0.01% | 1876 |
|
|
2022
Q4 | $9.25M | Buy |
671,863
+14,113
| +2% | +$216K | ﹤0.01% | 2064 |
|
|
2022
Q3 | $12.6M | Buy |
657,750
+384
| +0.1% | +$7K | ﹤0.01% | 1824 |
|
|
2022
Q2 | $10M | Sell |
657,366
-6,995
| -1% | -$103K | ﹤0.01% | 2035 |
|
|
2022
Q1 | $13.5M | Sell |
664,361
-102,435
| -13% | -$2.09M | ﹤0.01% | 1953 |
|
|
2021
Q4 | $22.4M | Buy |
766,796
+60,928
| +9% | +$1.74M | ﹤0.01% | 1679 |
|
|
2021
Q3 | $15.2M | Sell |
705,868
-22,612
| -3% | -$546K | ﹤0.01% | 1983 |
|
|
2021
Q2 | $18.7M | Buy |
728,480
+71,241
| +11% | +$1.52M | ﹤0.01% | 1931 |
|
|
2021
Q1 | $12M | Sell |
657,239
-10,101
| -2% | -$168K | ﹤0.01% | 2184 |
|
|
2020
Q4 | $7.7M | Sell |
667,340
-4,798
| -0.7% | -$43.9K | ﹤0.01% | 2419 |
|
|
2020
Q3 | $5.12M | Sell |
672,138
-25,439
| -4% | -$193K | ﹤0.01% | 2512 |
|
|
2020
Q2 | $4.58M | Buy |
697,577
+23,443
| +3% | +$131K | ﹤0.01% | 2575 |
|
|
2020
Q1 | $3.44M | Buy |
674,134
+25,384
| +4% | +$154K | ﹤0.01% | 2519 |
|
|
2019
Q4 | $4.98M | Buy |
648,750
+5,138
| +0.8% | +$30K | ﹤0.01% | 2588 |
|
|
2019
Q3 | $3.41M | Buy |
643,612
+45,633
| +8% | +$283K | ﹤0.01% | 2780 |
|
|
2019
Q2 | $3.35M | Buy |
597,979
+16,715
| +3% | +$68.9K | ﹤0.01% | 2779 |
|
|
2019
Q1 | $2.47M | Sell |
581,264
-19,699
| -3% | -$80.4K | ﹤0.01% | 2946 |
|
|
2018
Q4 | $2.46M | Sell |
600,963
-18,707
| -3% | -$97.6K | ﹤0.01% | 2934 |
|
|
2018
Q3 | $4.25M | Buy |
619,670
+50,784
| +9% | +$301K | ﹤0.01% | 2778 |
|
|
2018
Q2 | $2.23M | Buy |
568,886
+451,916
| +386% | +$1.57M | ﹤0.01% | 3157 |
|
|
2018
Q1 | $342K | Buy |
116,970
+44,826
| +62% | +$138K | ﹤0.01% | 3672 |
|
|
2017
Q4 | $280K | Sell |
72,144
-5,726
| -7% | -$24.5K | ﹤0.01% | 3703 |
|
|
2017
Q3 | $244K | Buy |
77,870
+12,948
| +20% | +$48.6K | ﹤0.01% | 3736 |
|
|
2017
Q2 | $276K | Buy |
64,922
+5,515
| +9% | +$22.6K | ﹤0.01% | 3698 |
|
|
2017
Q1 | $272K | Buy |
59,407
+6,423
| +12% | +$21.5K | ﹤0.01% | 3697 |
|
|
2016
Q4 | $115K | Buy |
52,984
+1,581
| +3% | +$3.7K | ﹤0.01% | 3874 |
|
|
2016
Q3 | $155K | Sell |
51,403
-49
| -0.1% | -$132 | ﹤0.01% | 3798 |
|
|
2016
Q2 | $131K | Sell |
51,452
-268,053
| -84% | -$747K | ﹤0.01% | 3821 |
|
|
2016
Q1 | $942K | Buy |
319,505
+20,219
| +7% | +$108K | ﹤0.01% | 3277 |
|
|
2015
Q4 | $2.45M | Buy |
299,286
+17,910
| +6% | +$145K | ﹤0.01% | 2933 |
|
|
2015
Q3 | $2.01M | Buy |
281,376
+16,977
| +6% | +$142K | ﹤0.01% | 3053 |
|
|
2015
Q2 | $2.42M | Buy |
264,399
+714
| +0.3% | +$6.87K | ﹤0.01% | 2966 |
|
|
2015
Q1 | $2.49M | Buy |
263,685
+2,438
| +0.9% | +$23.5K | ﹤0.01% | 2994 |
|
|
2014
Q4 | $2.54M | Sell |
261,247
-11,262
| -4% | -$113K | ﹤0.01% | 2944 |
|
|
2014
Q3 | $2.6M | Sell |
272,509
-3,355
| -1% | -$37.6K | ﹤0.01% | 2928 |
|
|
2014
Q2 | $3.63M | Sell |
275,864
-20,553
| -7% | -$259K | ﹤0.01% | 2737 |
|
|
2014
Q1 | $3.94M | Sell |
296,417
-20,083
| -6% | -$264K | ﹤0.01% | 2704 |
|
|
2013
Q4 | $3.08M | Buy |
316,500
+40,174
| +15% | +$378K | ﹤0.01% | 2894 |
|
|
2013
Q3 | $2.71M | Buy |
276,326
+179,177
| +184% | +$1.78M | ﹤0.01% | 2911 |
|
|
2013
Q2 | $878K | Buy |
+97,149
| New | +$1.02M | ﹤0.01% | 3307 |
|
Other funds holding CDMO
Northern Trust's CDMO Position: Q1 2025 in Review
Northern Trust sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 642,176 shares — an estimated $7.93M sold.
Northern Trust first reported a position in CDMO in Q2 2013 and held it in 47 quarters. The position peaked at $22.4M in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Northern Trust reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Northern Trust sold 642,176 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $7.93M.
- Northern Trust first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 47 quarters.
- Northern Trust's Avid Bioservices, Inc. Common Stock position peaked at $22.4M in Q4 2021.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Northern Trust's 13F filing for Q1 2025, filed 13 May 2025.